Experimental evidence for lack of homodimerization of the G protein-coupled human N-formyl peptide receptor

Journal of Immunology

Volumn 171, Issue 6, 2003, Pages 3187-3193

  Gripentrog, Jeannie M ^a   Kantele, Katrin P ^a   Jesaitis, Algirdas J ^a   Miettinen, Heini M ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYLPEPTIDE RECEPTOR; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CHEMOTAXIS; CHO CELL; CONTROLLED STUDY; CROSS LINKING; DIMERIZATION; ENDOCYTOSIS; IMMUNOPRECIPITATION; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0041331661     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.6.3187     Document Type: Article

References (34)

1. Ye, R. D., and F. Boulay. 1997. Structure and function of leukocyte chemoattractant receptors. Adv. Phamacol. 39:221.
2. Schiffmann, E., H. V. Showell, B. A. Corcoran, P. A. Ward, E. Smith, and E. L. Becker. 1975. The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J. Immunol. 114:1831.
3. Su, S. B., W. H. Gong, J. L. Gao, W. P. Shen, M. C. Grimm, X. Y. Deng, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1gp41, is an activator of human phagocyte N-formyl peptide receptor. Blood 93:3885.
4. Gao, J. L., E. L. Becker, R. J. Freer, N. Muthukumaraswamy, and P. M. Murphy. 1994. A high potency nonformylated peptide agonist for the phagocyte N-formyllpeptide chemotactic receptor. J. Exp. Med. 180:2191.
5. Higgins, J. D. I., G. J. Bridger, C. K. Derian, M. J. Beblavy, P. E. Hemandez, F. E. Gaul, M. J. Abrams, M. C. Pike, and H. F. Solomon. 1996. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor. J. Med. Chem. 39:1013.
6. Derian, C. K., H. F. Solomon, J. D. I. Higgins, M. J. Beblavy, R. J. Santulli, G. J. Bridger, M. C. Pike, D. J. Kroon, and A. J. Fischman. 1996. Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues. Biochemisto, 35:1256.
7. Hartt, J. K., T. Liang, A. Sahagun-Ruiz, J. M. Wang, J. L. Gao, and P. M. Murphy. 2000. The HIV-1 cell entry inhibitor T-20 potently chemoattracts neutrophils by specifically activating the N-formylpeptide receptor. Biochem. Biophys. Res. Commun. 272:699.
8. 1 integrin. J. Cell Sci. 111:1921.
9. Gripentrog, J. M., A. J. Jesaitis, and H. M. Miettinen. 2000. A single amino acid substitution (N297A) in the conserved NPXXY sequence of the human N-formyl peptide receptor results in inhibition of desensitization and endocytosis and a dose-dependent shift in p42/44 mitogen-activated protein kinase activation and chemotaxis. Biochem. J. 352:399.
10. Gomes, I., B. A. Jordan, A. Gupta, C. Rios, N. Trapaidze, and L. A. Devi. 2001. G protein coupled receptor dimerization: implications in modulating receptor function. J. Mol. Med. 79:226.
11. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation, J. Biol. Chem. 271:16384.
12. Cvejic, S., and L. A. Devi. 1997. Dimerization of the 8 opioid receptor: Implication for a role in receptor internalization. J. Biol. Chem. 272:26959.
13. Rocheville, M., D. C. Lange, U. Kumar, R. Sasi, R. C. Patel, and Y. C. Patel. 2000. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J. Biol, Chem. 275:7862.
14. Vila-Coro, A. J., J. M. Rodríguez-Frade, A. Martín de Ana, C. Moreno-Ortíz, C. Martínez-A, and M. Mellado. 1999. The chemokine SDF-1α triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 13:1699.
15. Rodríguez-Frade, J. M., A. J. Vila-Coro, A. M. De Ana, J. P. Albar, A. Martínez, and M. Mellado. 1999. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc. Natl. Acad. Sci. USA 96:3628.
16. Vila-Coro, A. J., M. Mellado, A. M. De Ana, P. Lucas, G. del Real, C. Martínez-A, and J. M. Rodríguez-Frade. 2000. HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. Proc. Natl. Acad. Sci. USA 97:3388.
17. Chelli, M., and M. Alizon. 2002. Rescue of HIV-1 receptor function through cooperation between different forms of the CCR5 chemokine receptor. J. Biol. Chem. 277:39388.
18. Le Gouill, C., J.-L. Parent, C.-A. Caron, R. Gaudreau, L. Volkov, M. Rola-Pleszczynski, and J. Stankova. 1999. Selective modulation of wild type receptor functions by mutants of G-protein-coupled receptors. J. Biol. Chem. 274:12548.
19. Miettinen, H. M., J. S. Mills, J. M. Gripentrog, E. A. Dratz, B. L. Granger, and A. J. Jesaitis. 1997. The ligand binding site of the formyl peptide receptor maps in the transmembrane region. J. Immunol. 159:4045.
20. Miettinen, H. M., J. M. Gripentrog, M. M. Mason, and A. J. Jesaitis. 1999. Identification of putative sites of interaction between the human formyl peptide receptor and G protein. J. Biol. Chem. 274:27934.
21. Uthayakumar, S.. and B. L. Granger. 1995. Cell surface accumulation of over-expressed hamster lysosomal membrane glycoproteins. Cell. Mol. Biol. Res. 41:405.
22. Evan, G. I., G. K. Lewis, G. Ramsay, and J. M. Bishop. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610.
23. Prossnitz, E. R., R. E. Schreiber, G. M. Bokoch, and R. D. Ye. 1995. Binding of low affinity N-formyl peptide receptors to G protein: characterization of a novel inactive receptor intermediate. J. Biol. Chem. 270:10686.
24. Angers, S., A. Salahpour, and M. Bouvier. 2002. Dimerization: An emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42:409.
25. Breceptor heterodimers. Neuropsychopharmacology 23:S41.
26. Rocheville, M., D. C. Lange, U. Kumar, S. C. Patel, R. C. Patel, and K. D. Patel. 2000. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288:154.
27. Overton, M. C., and K. J. Blumer. 2000. G-protein-coupled receptors function as oligomers in vivo. Curr. Biol. 10:341.
28. 2-adrenergic receptor intemalization and ERK signaling efficacy. J. Biol. Chem. 277:35402.
29. 1-adrenergic receptors regulates receptor surface expression and dimerization. Biochem. Biophys. Res. Commun. 297:565.
30. Jordam B. A., and L. A. Devi. 1999. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399:697.
31. Gomes, I., B. A. Jordan, A. Gupta, N. Trapaidze, V. Nagy, and L. A. Devi. 2000. Heterodimerization of μ and δ opioid receptors: a role in opiate synergy. J. Neurosci. 20:RC110.
32. Kitayama, J., M. W. Carr, S. J. Roth, J. M. Buccola, and T. A. Springer. 1997. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils. J. Immunol. 158:2340.
33. Campbell, J. J., E. F. Foxman. and E. C. Butcher. 1997. Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration. Eur. J. Immunol. 27:2571.
34. Mellado, M., J. M. Rodríguez-Frade, A. J. Vila-Coro. S. Femández, A. M. De Ana, D. R. Jones, J. L. Torán, and A. Martínez. 2001. Chemokine receptor homo-or heterodimerization activates distinct signaling pathways. EMBO J. 20:2497.